Trevena CMO to Present at the BioCentury 22nd Annual Future Leaders in the Biotech Industry conference Mar 18, 2015 4:30pm EDT
Trevena to Host Conference Call on March 18th to Discuss Full Year 2014 Financial Results Mar 11, 2015 7:00am EDT
Trevena completes interim analysis and announces plans for ongoing Phase 2b BLAST-AHF trial of TRV027 in acute heart failure Mar 09, 2015 7:00am EDT
Trevena CEO to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24, 2015 7:00am EST
Trevena Announces Positive Results from Phase 1 Multiple Ascending Dose Study of TRV734 for Moderate to Severe Acute and Chronic Pain Feb 09, 2015 7:00am EST
